Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Mark Terry… Source: BioSpace You Might Also Like Meet the Professor Who Was the First to Question Theranos' Research February 19, 2017 AI Biotech, BioXcel Therapeutics, Files for $69M IPO February 12, 2018 AstraZeneca PLC Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D May 21, 2017
